SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending due to a flurry of new Department of Defense contract wins and heightened investor focus on the company's long-term role in the 'Golden Dome' missile defense initiative. The community is actively debating the stock's performance amid shifting geopolitical tensions, with discussions centering on whether the recent pullbacks offer a strategic entry point or if the sector faces broader structural headwinds.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors speculating on a potential bull run, driven by the belief that its drone defense technology and high-profile partnerships with major aerospace players are undervalued following a recent sharp drawdown. Community discourse is sharply divided between believers who view the stock as a prime, oversold entry point for long-term sector disruption and skeptical traders who are actively calling out the impact of recent dilution and insider activity on price performance.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following its first-quarter earnings report, where it exceeded revenue and EPS expectations while announcing a 4-for-1 stock split. Despite the positive results and increased full-year guidance, the stock experienced a significant pullback as investors engaged in profit-taking after a rapid multi-month rally that left the valuation vulnerable to any sign of slowing growth.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 ETF is currently trending as investors focus on sector rotation, with small caps showing relative strength as big tech cools off amid concerns about AI valuations and rising interest rates. Community discussion is heavily focused on critical pivot levels near 300, with many traders debating whether current price action signals a sustainable breakout or a potential bull trap ahead of key economic data.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors weigh strong backlog growth and strategic roles in major defense programs like the B-21 Raider against concerns regarding recent capital expenditure and sector-wide regulatory pressure. The community is actively debating the company's long-term valuation compared to high-growth autonomous drone players, while monitoring how upcoming government contract decisions and budget cycles will influence performance.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is attracting significant attention as investors speculate on a breakout driven by upcoming network upgrades and its perceived valuation gap compared to other major crypto assets. The community remains deeply divided, with bulls highlighting its transactional utility and potential for a squeeze, while bears argue that its lack of growth and persistent volatility signal an underlying lack of long-term demand.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as the community debates Bitcoin's long-term utility versus its status as a legacy crypto asset amidst significant market volatility. Conversations are heavily focused on the struggle for support near key liquidity levels, with traders debating whether institutional adoption stabilizes the asset or if it remains vulnerable to broader macro pressures and rotation into AI-related equities.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq is currently trending as investors weigh strong capital markets activity and record-breaking fundraising against broader market volatility and AI-driven sector rotations. The community is actively discussing the platform's role in the evolving IPO landscape, the impact of new AI model efficiency on tech valuations, and the structural implications of expanded trading infrastructure.

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

TransMedics Group is seeing intense community debate between those valuing the company as a long-term infrastructure play for organ transplant logistics and those concerned about margin compression, jet fuel costs, and recent volatility. Investors are closely monitoring record flight data and upcoming clinical trial catalysts as key signals for the company's growth trajectory and potential recovery from recent sell-offs.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors focus on the company's clear regulatory pathway for its wet AMD treatment, AXPAXLI, with community debate centered on whether a single pivotal trial is sufficient for FDA approval. Discussion is heavily split between long-term investors banking on a potential buyout or successful commercialization and short-sellers who remain skeptical of the drug's real-world market share potential against established competitors like Eylea HD.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders?

Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders? Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 2, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...

J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?

JNJ and ABBV both offer solid long-term growth potential, but differences in diversification, pipeline strength and estimates may give one stock an edge.

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, approvals and deal activity adding momentum.

AbbVie (ABBV) to Acquire Apogee Therapeutics

AbbVie (ABBV) to Acquire Apogee Therapeutics...

Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy

Major M&A deals this week include: Adobe buys Topaz Labs, Rise Baking Company purchases Jimmy's Gourmet Bakery.read more...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

AbbVie's Costly Apogee Acquisition Has Long-Term Upside: Analyst

AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology growth despite near-term dilution.read more...

ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout

AbbVie shares jump after its $10.9B Apogee deal adds late-stage eczema and respiratory candidates, deepening its immunology pipeline.

Company News for Jun 23, 2026

Companies in The News Are: APGE, ABBV, DLR, META, SNDK

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Apogee Therapeutics Inc.

Why Did INTC, KEEL, APGE Stocks Hit 52-Week Highs Today?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$132.91
Prev Close	$132.77
Open	$133.60
Dividend Yield	0.00%
50-Day Moving Average	$92.61
Beta	0.00
Avg. Volume	5.49M
PE Ratio	-30.71

52-Week High	$133.85
52-Week Low	$34.34
Market Capitalization	$9.99B
EPS (Annual)	-$4.22
Price to Book	7.93
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

APGEApogee Therapeutics

Latest APGE News